Interleukin‐1 blockade in heart failure with preserved ejection fraction: rationale and design of the Diastolic Heart Failure Anakinra Response Trial 2 (D‐HART2)

Heart failure with preserved ejection fraction (HFpEF) now accounts for the majority of confirmed HF cases in the United States. However, there are no highly effective evidence‐based treatments currently available for these patients. Inflammation correlates positively with adverse outcomes in HF pat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cardiol
Main Authors: Van Tassell, Benjamin W., Buckley, Leo F., Carbone, Salvatore, Trankle, Cory R., Canada, Justin M., Dixon, Dave L., Abouzaki, Nayef, Oddi‐Erdle, Claudia, Biondi‐Zoccai, Giuseppe, Arena, Ross, Abbate, Antonio
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley Periodicals, Inc. 2017
Assuntos:
Trial Designs
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5744484/
https://ncbi.nlm.nih.gov/pubmed/28475816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22719
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados